The Molecular Biology of Myeloma

David S. Siegel, MD, PhD
Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.

September 2, 2015

Challenges with Oral Oncolytics for Healthcare Practitioners

As more oral oncolytics are developed, choosing the right regimen for prolonged disease-free survival presents a major patient management challenge. Dixie-Lee Esseltine, MD and George Mulligan, PhD explain that healthcare practitioners will have to make informed choices by balancing information emerging across similar trials.

October 16, 2015

Dermatologists and Medical Oncologists: Working Together

Dr. Sanjiv Agarwala gives an overview of the roles dermatologists and medical oncologists play and expands on how and why they need to work together to improve cancer care.